1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
60ACE6EBA436AF87F00258541004C939F
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/SearchNew?OpenForm&Query=(strategic%20planning)%20and%20(field%20ItemCatalog%3DBMR)&SearchWV=1&ItemCatalog=BMR&SearchOrder=1&Start=51&Count=10
18
19OpenForm&Query=(strategic%20planning)%20and%20(field%20ItemCatalog%3DBMR)&SearchWV=1&ItemCatalog=BMR&SearchOrder=1&Start=51&Count=10
2034.239.172.52
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




Search Results

Results 51 - 60 of 101 Total Hits, Sorted by Relevance.

    |    

Best Practices in Establishing Medical Affairs Capabilities in Emerging Countries: Using Structure, Staffing, and Responsibilities to Create an Effective Medical Affairs Group in TMEADirect access to this research is not included with your membership level.

With pharmaceutical companies facing diverse markets around the world, it is challenging to create and maintain an effective Medical Affairs group in... (ID POP-289)
Companies Profiled: Abbvie, AstraZeneca, Celgene, Gilead Sciences, more ...

Medical Affairs' Role in Patient Engagement ActivitiesDirect access to this research is not included with your membership level.

The medical affairs function continues its evolution from a support-only function into an independent role, one that is critical to the success of pharmaceutical companies... (ID POP-280)
Companies Profiled: Abbvie, Actelion, Alkermes, AstraZeneca, more ...

Creating and Maintaining a Strategic KOL Management and Engagement SystemDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics, Graphics and a practice summary Matrix.This document contains Metrics, Graphics and a practice summary Matrix.This document contains Metrics, Graphics and a practice summary Matrix.

Key Opinion Leaders (KOLs) are recognized as one of the most effective avenues for building awareness in medical and scientific communities... (ID POP-253)
Companies Profiled: Abbott Nutrition, Marcyrl, Antibiotice, Abbvie, more ...

Best Practices in Building Your Corporate Value PropositionDirect access to this research is not included with your membership level.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

A corporate brand is a single, clear promise that a company makes and fulfills for its stakeholders... (ID POP-250)

Risk Mitigation Excellence: Innovative Models & Trends in Supporting REMS & RMP ProgramsDirect access to this research is not included with your membership level.

With ever increasing regulatory requirements in place for healthcare companies and their new products, pharmaceutical organizations must develop inno... (ID POP-242)
Companies Profiled: Baxter International, Genericon Pharma, Actelion, MannKind Corporation, more ...

Driving Growth through New Product Planning and Strategic AlliancesDirect access to this research is not included with your membership level.

Drive overall growth through a well-managed portfolio by addressing current and long-term needs in your company's new product planning and strategic alliance systems... (ID SM-135)
Companies Profiled: Amgen, Eli Lilly, Janssen, Pfizer

Best Practices in Pharmaceutical Conventions ManagementDirect access to this research is not included with your membership level.

Learn how top pharmaceutical companies transform their conventions departments from tactical implementors to strategic innovators... (ID SM-159)
Companies Profiled: 3M, Amgen, AstraZeneca, Bayer, more ...

Pathways to Pharmacy Relations ExcellenceDirect access to this research is not included with your membership level.

Benefit from specific financial and operational recommendations as well as guiding principles for success... (ID PSM-202)

$1124.00

From Genes to Giants: Best Practices in Early-Stage Product CommercializationDirect access to this research is not included with your membership level.

Long and costly product development cycles make it essential today for pharmaceutical companies to allocate resources to the development of compounds with the greatest potential market value... (ID SM-162)
Companies Profiled: Abbott, Allergan, Bayer, Boehringer-Ingelheim, more ...

Best Practices in Managing Public RelationsDirect access to this research is not included with your membership level.

Manage staffing and budgets for your external affairs department, as well as assign proper roles and responsibilities... (ID SM-154)
Companies Profiled: AEP, Cogentrix, Mirant, NRG Energy, more ...